Pesquisa | BVS Doenças Infecciosas e Parasitárias

1.

Organoid cultures derived from patients with advanced prostate cancer.

Gao, Dong; Vela, Ian; Sboner, Andrea; Iaquinta, Phillip J; Karthaus, Wouter R; Gopalan, Anuradha; Dowling, Catherine; Wanjala, Jackline N; Undvall, Eva A; Arora, Vivek K; Wongvipat, John; Kossai, Myriam; Ramazanoglu, Sinan; Barboza, Luendreo P; Di, Wei; Cao, Zhen; Zhang, Qi Fan; Sirota, Inna; Ran, Leili; MacDonald, Theresa Y; Beltran, Himisha; Mosquera, Juan-Miguel; Touijer, Karim A; Scardino, Peter T; Laudone, Vincent P; Curtis, Kristen R; Rathkopf, Dana E; Morris, Michael J; Danila, Daniel C; Slovin, Susan F; Solomon, Stephen B; Eastham, James A; Chi, Ping; Carver, Brett; Rubin, Mark A; Scher, Howard I; Clevers, Hans; Sawyers, Charles L; Chen, Yu.

Cell ; 159(1): 176-187, 2014 Sep 25.

Artigo em Inglês | MEDLINE | ID: mdl-25201530

2.

Replication competent retrovirus testing (RCR) in the National Gene Vector Biorepository: No evidence of RCR in 1,595 post-treatment peripheral blood samples obtained from 60 clinical trials.

Cornetta, Kenneth; Yao, Jing; House, Kimberley; Duffy, Lisa; Adusumilli, Prasad S; Beyer, Rachel; Booth, Claire; Brenner, Malcolm; Curran, Kevin; Grilley, Bambi; Heslop, Helen; Hinrichs, Christian S; Kaplan, Rosandra N; Kiem, Hans-Peter; Kochenderfer, James; Kohn, Donald B; Mailankody, Sham; Norberg, Scott M; O'Cearbhaill, Roisin E; Pappas, Jennifer; Park, Jae; Ramos, Carlos; Ribas, Antonio; Rivière, Isabelle; Rosenberg, Steven A; Sauter, Craig; Shah, Nirali N; Slovin, Susan F; Thrasher, Adrian; Williams, David A; Lin, Tsai-Yu.

Mol Ther ; 31(3): 801-809, 2023 03 01.

Artigo em Inglês | MEDLINE | ID: mdl-36518078

3.

Immunotherapy combinations for metastatic castration-resistant prostate cancer - failed trials and future aspects.

Slovin, Susan F.

Curr Opin Urol ; 33(5): 390-395, 2023 09 01.

Artigo em Inglês | MEDLINE | ID: mdl-37395505

4.

Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Prostate Cancer: The Primary Results of the PRONOUNCE Randomized Trial.

Lopes, Renato D; Higano, Celestia S; Slovin, Susan F; Nelson, Adam J; Bigelow, Robert; Sørensen, Per S; Melloni, Chiara; Goodman, Shaun G; Evans, Christopher P; Nilsson, Jan; Bhatt, Deepak L; Clarke, Noel W; Olesen, Tine K; Doyle-Olsen, Belinda T; Kristensen, Henriette; Arney, Lauren; Roe, Matthew T; Alexander, John H.

Circulation ; 144(16): 1295-1307, 2021 10 19.

Artigo em Inglês | MEDLINE | ID: mdl-34459214

5.

Clinical annotations for prostate cancer research: Defining data elements, creating a reproducible analytical pipeline, and assessing data quality.

Keegan, Niamh M; Vasselman, Samantha E; Barnett, Ethan S; Nweji, Barbara; Carbone, Emily A; Blum, Alexander; Morris, Michael J; Rathkopf, Dana E; Slovin, Susan F; Danila, Daniel C; Autio, Karen A; Scher, Howard I; Kantoff, Philip W; Abida, Wassim; Stopsack, Konrad H.

Prostate ; 82(11): 1107-1116, 2022 08.

Artigo em Inglês | MEDLINE | ID: mdl-35538298

6.

American Cancer Society prostate cancer survivorship care guidelines.

Skolarus, Ted A; Wolf, Andrew M D; Erb, Nicole L; Brooks, Durado D; Rivers, Brian M; Underwood, Willie; Salner, Andrew L; Zelefsky, Michael J; Aragon-Ching, Jeanny B; Slovin, Susan F; Wittmann, Daniela A; Hoyt, Michael A; Sinibaldi, Victoria J; Chodak, Gerald; Pratt-Chapman, Mandi L; Cowens-Alvarado, Rebecca L.

CA Cancer J Clin ; 64(4): 225-49, 2014.

Artigo em Inglês | MEDLINE | ID: mdl-24916760

7.

Evolving understanding and categorization of prostate cancer: preventing progression to metastatic castration-resistant prostate cancer: RADAR IV.

Crawford, E David; Andriole, Gerald; Freedland, Stephen J; Garnick, Marc; Gomella, Leonard G; Henderson, Jonathan; Higano, Celestia Tia; Kader, Andrew Karim; Kane, Christopher; Keane, Thomas E; Koo, Phillip J; Petrylak, Daniel P; Reiter, Robert E; Slovin, Susan F; Yu, Evan Y.

Can J Urol ; 27(5): 10352-10362, 2020 10.

Artigo em Inglês | MEDLINE | ID: mdl-33049187

8.

A phase 2 trial of abiraterone acetate without glucocorticoids for men with metastatic castration-resistant prostate cancer.

McKay, Rana R; Werner, Lillian; Jacobus, Susanna J; Jones, Alexandra; Mostaghel, Elahe A; Marck, Brett T; Choudhury, Atish D; Pomerantz, Mark M; Sweeney, Christopher J; Slovin, Susan F; Morris, Michael J; Kantoff, Philip W; Taplin, Mary-Ellen.

Cancer ; 125(4): 524-532, 2019 02 15.

Artigo em Inglês | MEDLINE | ID: mdl-30427533

9.

A Clinician's Guide to Next Generation Imaging in Patients With Advanced Prostate Cancer (RADAR III).

Crawford, E David; Koo, Phillip J; Shore, Neal; Slovin, Susan F; Concepcion, Raoul S; Freedland, Stephen J; Gomella, Leonard G; Karsh, Lawrence; Keane, Thomas E; Maroni, Paul; Penson, David; Petrylak, Daniel P; Ross, Ashley; Mouraviev, Vlad; Reiter, Robert E; Divgi, Chaitanya; Yu, Evan Y.

J Urol ; 201(4): 682-692, 2019 04.

Artigo em Inglês | MEDLINE | ID: mdl-30077557

10.

A phase I study of the antibody drug conjugate ASG-5ME, an SLC44A4-targeting antibody carrying auristatin E, in metastatic castration-resistant prostate cancer.

McHugh, Deaglan; Eisenberger, Mario; Heath, Elisabeth I; Bruce, Justine; Danila, Daniel C; Rathkopf, Dana E; Feldman, Jarett; Slovin, Susan F; Anand, Banmeet; Chu, Rong; Lackey, Jacqueline; Reyno, Leonard; Antonarakis, Emmanuel S; Morris, Michael J.

Invest New Drugs ; 37(5): 1052-1060, 2019 10.

Artigo em Inglês | MEDLINE | ID: mdl-30725389

11.

Sipuleucel-T: When and for Whom to Recommend It.

Slovin, Susan F.

Oncology (Williston Park) ; 31(12): 900-1, 910-2, 2017 12 15.

Artigo em Inglês | MEDLINE | ID: mdl-29297175

12.

Immunotherapy for prostate cancer: is prostate an immune responsive tumor?

Slovin, Susan F.

Curr Opin Urol ; 26(6): 529-34, 2016 11.

Artigo em Inglês | MEDLINE | ID: mdl-27533500

13.

Immunotherapy in metastatic prostate cancer.

Slovin, Susan F.

Indian J Urol ; 32(4): 271-276, 2016.

Artigo em Inglês | MEDLINE | ID: mdl-27843208

14.

Development of thyroglobulin antibodies after GVAX immunotherapy is associated with prolonged survival.

De Remigis, Alessandra; de Gruijl, Tanja D; Uram, Jennifer N; Tzou, Schey-Cherng; Iwama, Shintaro; Talor, Monica V; Armstrong, Todd D; Santegoets, Saskia J A M; Slovin, Susan F; Zheng, Lei; Laheru, Daniel A; Jaffee, Elizabeth M; Gerritsen, Winald R; van den Eertwegh, Alfons J M; Le, Dung T; Caturegli, Patrizio.

Int J Cancer ; 136(1): 127-37, 2015 Jan 01.

Artigo em Inglês | MEDLINE | ID: mdl-24832153

15.

Everolimus combined with gefitinib in patients with metastatic castration-resistant prostate cancer: Phase 1/2 results and signaling pathway implications.

Rathkopf, Dana E; Larson, Steven M; Anand, Aseem; Morris, Michael J; Slovin, Susan F; Shaffer, David R; Heller, Glenn; Carver, Brett; Rosen, Neal; Scher, Howard I.

Cancer ; 121(21): 3853-61, 2015 Nov 01.

Artigo em Inglês | MEDLINE | ID: mdl-26178426

16.

Repetitively dosed docetaxel and ¹5³samarium-EDTMP as an antitumor strategy for metastatic castration-resistant prostate cancer.

Autio, Karen A; Pandit-Taskar, Neeta; Carrasquillo, Jorge A; Stephenson, Ryan D; Slovin, Susan F; Rathkopf, Dana E; Hong, Christina; Heller, Glenn; Scher, Howard I; Larson, Steven M; Morris, Michael J.

Cancer ; 119(17): 3186-94, 2013 Sep 01.

Artigo em Inglês | MEDLINE | ID: mdl-23765638

17.

Phase I pharmacokinetic and biodistribution study with escalating doses of ²²³Ra-dichloride in men with castration-resistant metastatic prostate cancer.

Carrasquillo, Jorge A; O'Donoghue, Joseph A; Pandit-Taskar, Neeta; Humm, John L; Rathkopf, Dana E; Slovin, Susan F; Williamson, Matthew J; Lacuna, Kristine; Aksnes, Anne-Kirsti; Larson, Steven M; Scher, Howard I; Morris, Michael J.

Eur J Nucl Med Mol Imaging ; 40(9): 1384-93, 2013 Sep.

Artigo em Inglês | MEDLINE | ID: mdl-23653243

18.

Genomic Portraits: Reflections into a Tumor's Response to Therapy.

Slovin, Susan F.

Clin Cancer Res ; 29(21): 4323-4325, 2023 11 01.

Artigo em Inglês | MEDLINE | ID: mdl-37646769

19.

An AI Predictive Model to Determine Who Benefits from ADT with Radiation: Working Smarter, Not Harder.

Slovin, Susan F.

NEJM Evid ; 2(8): EVIDe2300146, 2023 Aug.

Artigo em Inglês | MEDLINE | ID: mdl-38320151

20.

Randomized Phase II Multicenter Trial of Abiraterone Acetate With or Without Cabazitaxel in the Treatment of Metastatic Castration-Resistant Prostate Cancer.

Slovin, Susan F; Knudsen, Karen; Halabi, Susan; de Leeuw, Renee; Shafi, Ayesha; Kang, Praneet; Wolf, Steven; Luo, Bin; Gopalan, Anuradha; Curley, Tracy; Fleming, Mark; Molina, Ana; Fernandez, Celina; Kelly, Kevin.

J Clin Oncol ; 41(32): 5015-5024, 2023 Nov 10.

Artigo em Inglês | MEDLINE | ID: mdl-37582240

BVS Doenças Infecciosas e Parasitárias

Informação e Conhecimento para a Saúde

Configurar filtros

Sua seleção (0)

Formato de exportação:

Exportar:

Organoid cultures derived from patients with advanced prostate cancer.

Replication competent retrovirus testing (RCR) in the National Gene Vector Biorepository: No evidence of RCR in 1,595 post-treatment peripheral blood samples obtained from 60 clinical trials.

Immunotherapy combinations for metastatic castration-resistant prostate cancer - failed trials and future aspects.

Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Prostate Cancer: The Primary Results of the PRONOUNCE Randomized Trial.

Clinical annotations for prostate cancer research: Defining data elements, creating a reproducible analytical pipeline, and assessing data quality.

American Cancer Society prostate cancer survivorship care guidelines.

Evolving understanding and categorization of prostate cancer: preventing progression to metastatic castration-resistant prostate cancer: RADAR IV.

A phase 2 trial of abiraterone acetate without glucocorticoids for men with metastatic castration-resistant prostate cancer.

A Clinician's Guide to Next Generation Imaging in Patients With Advanced Prostate Cancer (RADAR III).

A phase I study of the antibody drug conjugate ASG-5ME, an SLC44A4-targeting antibody carrying auristatin E, in metastatic castration-resistant prostate cancer.

Sipuleucel-T: When and for Whom to Recommend It.

Immunotherapy for prostate cancer: is prostate an immune responsive tumor?

Immunotherapy in metastatic prostate cancer.

Development of thyroglobulin antibodies after GVAX immunotherapy is associated with prolonged survival.

Everolimus combined with gefitinib in patients with metastatic castration-resistant prostate cancer: Phase 1/2 results and signaling pathway implications.

Repetitively dosed docetaxel and ¹5³samarium-EDTMP as an antitumor strategy for metastatic castration-resistant prostate cancer.

Phase I pharmacokinetic and biodistribution study with escalating doses of ²²³Ra-dichloride in men with castration-resistant metastatic prostate cancer.

Genomic Portraits: Reflections into a Tumor's Response to Therapy.

An AI Predictive Model to Determine Who Benefits from ADT with Radiation: Working Smarter, Not Harder.

Randomized Phase II Multicenter Trial of Abiraterone Acetate With or Without Cabazitaxel in the Treatment of Metastatic Castration-Resistant Prostate Cancer.